These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19487291)

  • 1. Bacterial cytosine deaminase mutants created by molecular engineering show improved 5-fluorocytosine-mediated cell killing in vitro and in vivo.
    Fuchita M; Ardiani A; Zhao L; Serve K; Stoddard BL; Black ME
    Cancer Res; 2009 Jun; 69(11):4791-9. PubMed ID: 19487291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of enzyme and pathway engineering strategies for 5FC-mediated suicide gene therapy applications.
    Johnson AJ; Ardiani A; Sanchez-Bonilla M; Black ME
    Cancer Gene Ther; 2011 Aug; 18(8):533-42. PubMed ID: 21394105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular chemotherapy of pancreatic cancer using novel mutant bacterial cytosine deaminase gene.
    Kaliberova LN; Della Manna DL; Krendelchtchikova V; Black ME; Buchsbaum DJ; Kaliberov SA
    Mol Cancer Ther; 2008 Sep; 7(9):2845-54. PubMed ID: 18790765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine.
    Stolworthy TS; Korkegian AM; Willmon CL; Ardiani A; Cundiff J; Stoddard BL; Black ME
    J Mol Biol; 2008 Mar; 377(3):854-69. PubMed ID: 18291415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy.
    Mahan SD; Ireton GC; Knoeber C; Stoddard BL; Black ME
    Protein Eng Des Sel; 2004 Aug; 17(8):625-33. PubMed ID: 15381761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.
    Kievit E; Nyati MK; Ng E; Stegman LD; Parsels J; Ross BD; Rehemtulla A; Lawrence TS
    Cancer Res; 2000 Dec; 60(23):6649-55. PubMed ID: 11118048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of mutant bacterial cytosine deaminase gene for colon cancer.
    Deng LY; Wang JP; Gui ZF; Shen LZ
    World J Gastroenterol; 2011 Jun; 17(24):2958-64. PubMed ID: 21734808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine.
    Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG
    Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transduction of cytosine deaminase gene makes rat glioma cells highly sensitive to 5-fluorocytosine.
    Ge K; Xu L; Zheng Z; Xu D; Sun L; Liu X
    Int J Cancer; 1997 May; 71(4):675-9. PubMed ID: 9178825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
    Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
    Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma.
    Kaliberov SA; Market JM; Gillespie GY; Krendelchtchikova V; Della Manna D; Sellers JC; Kaliberova LN; Black ME; Buchsbaum DJ
    Gene Ther; 2007 Jul; 14(14):1111-9. PubMed ID: 17495948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alanine-scanning mutagenesis reveals a cytosine deaminase mutant with altered substrate preference.
    Mahan SD; Ireton GC; Stoddard BL; Black ME
    Biochemistry; 2004 Jul; 43(28):8957-64. PubMed ID: 15248753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.
    Topf N; Worgall S; Hackett NR; Crystal RG
    Gene Ther; 1998 Apr; 5(4):507-13. PubMed ID: 9614575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of cytosine deaminase with uracil phosphoribosyl transferase leads to local and distant bystander effects against RM1 prostate cancer in mice.
    Khatri A; Zhang B; Doherty E; Chapman J; Ow K; Pwint H; Martiniello-Wilks R; Russell PJ
    J Gene Med; 2006 Sep; 8(9):1086-96. PubMed ID: 16832832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined cytosine deaminase expression, 5-fluorocytosine exposure, and radiotherapy increases cytotoxicity to cholangiocarcinoma cells.
    Pederson LC; Vickers SM; Buchsbaum DJ; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    J Gastrointest Surg; 1998; 2(3):283-91. PubMed ID: 9841986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts.
    Kievit E; Bershad E; Ng E; Sethna P; Dev I; Lawrence TS; Rehemtulla A
    Cancer Res; 1999 Apr; 59(7):1417-21. PubMed ID: 10197605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bystander cytotoxicity in human medullary thyroid carcinoma cells mediated by fusion yeast cytosine deaminase and 5-fluorocytosine.
    Kucerova L; Matuskova M; Hlubinova K; Bohovic R; Feketeova L; Janega P; Babal P; Poturnajova M
    Cancer Lett; 2011 Dec; 311(1):101-12. PubMed ID: 21824724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation.
    Anello R; Cohen S; Atkinson G; Hall SJ
    J Urol; 2000 Dec; 164(6):2173-7. PubMed ID: 11061950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit.
    Lee KC; Hamstra DA; Bullarayasamudram S; Bhojani MS; Moffat BA; Dornfeld KJ; Ross BD; Rehemtulla A
    Gene Ther; 2006 Jan; 13(2):127-37. PubMed ID: 16163381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H; Zhang L; Tang Y; Deisseroth A
    Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.